Humanetics Awarded Patent Enabling Oral Administration of Powerful Radioprotectant

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MINNEAPOLIS--(BUSINESS WIRE)--Minneapolis-based Humanetics Corporation has been awarded a patent for a breakthrough formulation that increases the bioavailability of their proprietary radioprotectant compound, BIO 300.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC